|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 405/12 | (2006.01) |
| A61K 31/5377 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2836491 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13774979.2 |
| Date of filing the European patent application | 2013-04-11 | |
| (97) | Date of publication of the European application | 2015-02-18 |
| (45) | Date of publication and mention of the grant of the patent | 2016-12-07 |
| (46) | Date of publication of the claims translation | 2017-03-27 |
| (86) | Number | PCT/US2013/036193 |
| Date | 2013-04-11 |
| (87) | Number | WO 2013/155317 |
| Date | 2013-10-17 |
| (30) | Number | Date | Country code |
| 201261624215 P | 2012-04-13 | US |
| (72) |
KUNTZ, Kevin, Wayne, US
HUANG, Kuan-chun, US
CHOI, Hyeong, Wook, US
SANDERS, Kristen, US
MATHIEU, Steven, US
CHANDA, Arani, US
FANG, Frank, US
|
| (73) |
Eisai R&D Management Co., Ltd.,
6-10, Koishikawa 4-chome, Bunkyo-ku, Tokyo 112-8088,
JP
Epizyme, Inc., 400 Technology Square, 4th Floor, Cambridge, MA 02139, US |
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Žmogaus histono metiltransferazės EZH2 slopiklio druskos forma |
| SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2026-03-03 | 14 | 289.00 EUR |
| 2027-04-11 |